{"nctId":"NCT00700817","briefTitle":"The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus","startDateStruct":{"date":"2008-06"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"count":665,"armGroups":[{"label":"Lira 1.2 mg -> Lira 1.2 mg -> Lira 1.2 mg","type":"EXPERIMENTAL","interventionNames":["Drug: liraglutide","Drug: metformin"]},{"label":"Lira 1.8 mg -> Lira 1.8 mg -> Lira 1.8 mg","type":"EXPERIMENTAL","interventionNames":["Drug: metformin","Drug: liraglutide"]},{"label":"Sita -> Sita","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: sitagliptin","Drug: metformin"]},{"label":"Sita -> Sita -> Lira 1.2 mg","type":"EXPERIMENTAL","interventionNames":["Drug: liraglutide","Drug: sitagliptin","Drug: metformin"]},{"label":"Sita -> Sita -> Lira 1.8 mg","type":"EXPERIMENTAL","interventionNames":["Drug: sitagliptin","Drug: metformin","Drug: liraglutide"]}],"interventions":[{"name":"liraglutide","otherNames":[]},{"name":"sitagliptin","otherNames":[]},{"name":"metformin","otherNames":[]},{"name":"liraglutide","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Type 2 diabetes\n* Treatment with metformin alone for at least three months\n* HbA1c (glycosylated haemoglobin A1c) 7.5-10.0% (both inclusive)\n* Body Mass Index (BMI) less than or equal to 45.0\n\nExclusion Criteria:\n\n* Previous treatment with insulin, glucagon like peptide-1 (GLP-1) receptor agonists or dipeptidyl peptidase-4 (DPP-4) inhibitors\n* Treatment with anti-diabetic drugs other than metformin within the last three months\n* Any serious medical condition\n* Females who are pregnant, have the intention of becoming pregnant or are breastfeeding","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change From Baseline in Glycosylated Haemoglobin A1c (HbA1c) at Week 26","description":"Calculated as an estimate of the mean change from baseline in glycosylated haemoglobin A1c (HbA1c) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.24","spread":"0.07"},{"groupId":"OG001","value":"-1.5","spread":"0.06"},{"groupId":"OG002","value":"-0.9","spread":"0.07"}]}]}]},{"type":"PRIMARY","title":"Mean Change From Baseline in Glycosylated Haemoglobin A1c (HbA1c) at Week 52","description":"Calculated as an estimate of the mean change from baseline in glycosylated haemoglobin A1c (HbA1c) at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.29","spread":"0.07"},{"groupId":"OG001","value":"-1.51","spread":"0.07"},{"groupId":"OG002","value":"-0.88","spread":"0.07"}]}]}]},{"type":"PRIMARY","title":"Mean Change From Baseline in Glycosylated Haemoglobin A1c (HbA1c) at Week 78","description":"Calculated as an estimate of the mean change from baseline in glycosylated haemoglobin A1c (HbA1c) at Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.94","spread":"0.08"},{"groupId":"OG001","value":"-1.28","spread":"0.07"}]}]}]},{"type":"PRIMARY","title":"Mean Change in Glycosylated Haemoglobin A1c (HbA1c) From Week 52 to Week 78","description":"Mean Change in Glycosylated Haemoglobin A1c (HbA1c) from Week 52 to Week 78","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"-0.24","spread":"0.7"},{"groupId":"OG004","value":"-0.45","spread":"0.9"}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects Achieving Treatment Target of HbA1c < 7.0% at Week 26","description":"Calculated as the percentage of subjects achieving treatment target of HbA1c \\< 7.0% at Week 26","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"43","spread":null},{"groupId":"OG001","value":"55","spread":null},{"groupId":"OG002","value":"22","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects Achieving Treatment Target of HbA1c < 7.0% at Week 52","description":"Calculated as an estimate of the percentage of subjects achieving treatment target of HbA1c \\< 7.0% at Week 52","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null},{"groupId":"OG001","value":"63","spread":null},{"groupId":"OG002","value":"27","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects Achieving Treatment Target of HbA1c < 7.0% at Week 78","description":"Calculated as an estimate of the percentage of subjects achieving treatment target of HbA1c \\< 7.0% at Week 78. Based on the FAS.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35","spread":null},{"groupId":"OG001","value":"51","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects Achieving Treatment Target of HbA1c < 7.0% at Week 78","description":"Calculated as an estimate of the percentage of subjects achieving treatment target of HbA1c \\< 7.0% at Week 78. Based on the extension 2 FAS.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"49","spread":null},{"groupId":"OG004","value":"50","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects Achieving Treatment Target of HbA1c =< 6.5% at Week 26","description":"Calculated as the percentage of subjects achieving treatment target of HbA1c =\\< 6.5% at Week 26","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23","spread":null},{"groupId":"OG001","value":"36","spread":null},{"groupId":"OG002","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects Achieving Treatment Target of HbA1c =< 6.5% at Week 52","description":"Calculated as an estimate of the percentage of subjects achieving treatment target of HbA1c =\\< 6.5% at Week 52","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"40","spread":null},{"groupId":"OG002","value":"17","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects Achieving Treatment Target of HbA1c =< 6.5% at Week 78","description":"Calculated as an estimate of the percentage of subjects achieving treatment target of HbA1c =\\< 6.5% at Week 78. Based on the FAS.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"27","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects Achieving Treatment Target of HbA1c =< 6.5% at Week 78","description":"Calculated as an estimate of the percentage of subjects achieving treatment target of HbA1c =\\< 6.5% at Week 78. Based on the extension 2 FAS.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"29","spread":null},{"groupId":"OG004","value":"25","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Body Weight at Week 26","description":"Calculated as an estimate of the mean change from baseline in body weight at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.86","spread":"0.27"},{"groupId":"OG001","value":"-3.38","spread":"0.27"},{"groupId":"OG002","value":"-0.96","spread":"0.27"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Body Weight at Week 52","description":"Calculated as an estimate of the mean change from baseline in body weight at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.78","spread":"0.31"},{"groupId":"OG001","value":"-3.68","spread":"0.31"},{"groupId":"OG002","value":"-1.16","spread":"0.31"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Body Weight From Week 52 to Week 78","description":"Mean change in body weight from Week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"-1.64","spread":"3"},{"groupId":"OG004","value":"-2.48","spread":"3.6"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Fasting Plasma Glucose (FPG) at Week 26","description":"Calculated as an estimate of the mean change from baseline in fasting plasma glucose (FPG) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.87","spread":"0.15"},{"groupId":"OG001","value":"-2.14","spread":"0.15"},{"groupId":"OG002","value":"-0.83","spread":"0.15"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Fasting Plasma Glucose (FPG) at Week 52","description":"Calculated as an estimate of the mean change from baseline in fasting plasma glucose (FPG) at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.71","spread":"0.17"},{"groupId":"OG001","value":"-2.04","spread":"0.17"},{"groupId":"OG002","value":"-0.59","spread":"0.17"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Fasting Plasma Glucose (FPG) at Week 78","description":"Calculated as an estimate of the mean change in fasting plasma glucose (FPG) from baseline to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.30","spread":"0.18"},{"groupId":"OG001","value":"-1.65","spread":"0.18"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Fasting Plasma Glucose (FPG) From Week 52 to Week 78","description":"Mean change in fasting plasma glucose (FPG) Week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"-0.84","spread":"1.8"},{"groupId":"OG004","value":"-1.42","spread":"2.1"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Beta-cell Function at Week 26","description":"Calculated as an estimate of the mean change from baseline in beta-cell function at Week 26.\n\nDerived from fasting plasma glucose (FPG) and fasting insulin using the homeostatic model assessment (HOMA) method with the assumption that normal-weight subjects aged under 35 years have a 100% beta-cell function (HOMA-B).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27.23","spread":"3.82"},{"groupId":"OG001","value":"28.70","spread":"3.75"},{"groupId":"OG002","value":"4.18","spread":"3.79"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Beta-cell Function at Week 52","description":"Calculated as an estimate of the mean change from baseline in beta-cell function at Week 52.\n\nDerived from fasting plasma glucose (FPG) and fasting insulin using the homeostatic model assessment (HOMA) method with the assumption that normal-weight subjects aged under 35 years have a 100% beta-cell function (HOMA-B).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.58","spread":"3.31"},{"groupId":"OG001","value":"25.76","spread":"3.25"},{"groupId":"OG002","value":"3.98","spread":"3.30"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Beta-cell Function From Week 52 to Week 78","description":"Mean change in beta-cell function from Week 52 to Week 78. Derived from fasting plasma glucose (FPG) and fasting insulin using the homeostatic model assessment (HOMA) method with the assumption that normal-weight subjects aged under 35 years have a 100% beta-cell function (HOMA-B).","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"13.31","spread":"29.4"},{"groupId":"OG004","value":"23.09","spread":"43.7"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Total Cholesterol at Week 26","description":"Calculated as an estimate of the mean change from baseline in total cholesterol at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.03","spread":"0.06"},{"groupId":"OG001","value":"-0.17","spread":"0.05"},{"groupId":"OG002","value":"-0.02","spread":"0.05"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Total Cholesterol at Week 52","description":"Calculated as an estimate of the mean change from baseline in total cholesterol at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.01","spread":"0.06"},{"groupId":"OG001","value":"-0.09","spread":"0.06"},{"groupId":"OG002","value":"0.03","spread":"0.06"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Total Cholesterol From Week 52 to Week 78","description":"Mean change in total cholesterol from Week 52 to Week 78","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"-0.16","spread":"0.8"},{"groupId":"OG004","value":"-0.24","spread":"0.7"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Low-density Lipoprotein-cholesterol (LDL-C) at Week 26","description":"Calculated as an estimate of the mean change in low-density lipoprotein-cholesterol (LDL-C) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.08","spread":"0.05"},{"groupId":"OG001","value":"0.05","spread":"0.05"},{"groupId":"OG002","value":"0.13","spread":"0.05"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Low-density Lipoprotein-cholesterol (LDL-C) at Week 52","description":"Calculated as an estimate of the mean change in low-density lipoprotein-cholesterol (LDL-C) at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.09","spread":"0.05"},{"groupId":"OG001","value":"0.09","spread":"0.05"},{"groupId":"OG002","value":"0.17","spread":"0.05"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Low-density Lipoprotein-cholesterol (LDL-C) From Week 52 to Week 78","description":"Mean change in low-density lipoprotein-cholesterol (LDL-C) from week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"-0.22","spread":"0.7"},{"groupId":"OG004","value":"-0.25","spread":"0.6"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in High-density Lipoprotein-cholesterol (HDL-C) at Week 26","description":"Calculated as an estimate of the mean change from baseline in high-density lipoprotein-cholesterol (HDL-C) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.00","spread":"0.01"},{"groupId":"OG001","value":"0.00","spread":"0.01"},{"groupId":"OG002","value":"0.00","spread":"0.01"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in High-density Lipoprotein-cholesterol (HDL-C) at Week 52","description":"Calculated as an estimate of the mean change from baseline in high-density lipoprotein-cholesterol (HDL-C) at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.01","spread":"0.01"},{"groupId":"OG001","value":"0.02","spread":"0.01"},{"groupId":"OG002","value":"0.01","spread":"0.01"}]}]}]},{"type":"SECONDARY","title":"Mean Change in High-density Lipoprotein-cholesterol (HDL-C) From Week 52 to Week 78","description":"Mean change in high-density lipoprotein-cholesterol (HDL-C) from Week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"0.02","spread":"0.1"},{"groupId":"OG004","value":"-0.01","spread":"0.2"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Very Low-density Lipoprotein-cholesterol (VLDL-C) at Week 26","description":"Calculated as an estimate of the change from baseline in very low-density lipoprotein-cholesterol (VLDL-C) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.11","spread":"0.03"},{"groupId":"OG001","value":"-0.20","spread":"0.03"},{"groupId":"OG002","value":"-0.15","spread":"0.03"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Very Low-density Lipoprotein-cholesterol (VLDL-C) at Week 52","description":"Calculated as an estimate of the change from baseline in very low-density lipoprotein-cholesterol (VLDL-C) at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.11","spread":"0.04"},{"groupId":"OG001","value":"-0.19","spread":"0.04"},{"groupId":"OG002","value":"-0.15","spread":"0.04"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Very Low-density Lipoprotein-cholesterol (VLDL-C) at Week 52 to Week 78","description":"Mean change in very low-density lipoprotein-cholesterol (VLDL-C) from Week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"0.03","spread":"0.3"},{"groupId":"OG004","value":"0.02","spread":"0.3"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Triglycerides (TG) at Week 26","description":"Calculated as an estimate of the change from baseline in triglycerides (TG) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.19","spread":"0.10"},{"groupId":"OG001","value":"-0.43","spread":"0.09"},{"groupId":"OG002","value":"-0.40","spread":"0.09"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Triglycerides (TG) at Week 52","description":"Calculated as an estimate of the change from baseline in triglycerides (TG) at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.10","spread":"0.10"},{"groupId":"OG001","value":"-0.32","spread":"0.10"},{"groupId":"OG002","value":"-0.23","spread":"0.10"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Triglycerides (TG) From Week 52 to Week 78","description":"Mean change in triglycerides (TG) from Week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"-0.20","spread":"0.8"},{"groupId":"OG004","value":"-0.26","spread":"0.8"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Free Fatty Acids (FFA) at Week 26","description":"Calculated as an estimate of the change from baseline in free fatty acids (FFA) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.03","spread":"0.02"},{"groupId":"OG001","value":"-0.07","spread":"0.02"},{"groupId":"OG002","value":"-0.05","spread":"0.02"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Free Fatty Acids (FFA) at Week 52","description":"Calculated as an estimate of the change from baseline in free fatty acids (FFA) at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.07","spread":"0.02"},{"groupId":"OG001","value":"-0.10","spread":"0.02"},{"groupId":"OG002","value":"-0.06","spread":"0.02"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Free Fatty Acids (FFA) From Week 52 to Week 78","description":"Mean change in free fatty acids (FFA) from Week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"0.02","spread":"0.3"},{"groupId":"OG004","value":"-0.01","spread":"0.3"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Apolipoprotein B at Week 26","description":"Calculated as an estimate of the change from baseline in apolipoprotein B (ApoB) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.06","spread":"0.01"},{"groupId":"OG001","value":"-0.07","spread":"0.01"},{"groupId":"OG002","value":"-0.05","spread":"0.01"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Apolipoprotein B at Week 52","description":"Calculated as an estimate of the change from baseline in apolipoprotein B (ApoB) at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.03","spread":"0.01"},{"groupId":"OG001","value":"-0.03","spread":"0.01"},{"groupId":"OG002","value":"-0.03","spread":"0.01"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Apolipoprotein B From Week 52 to Week 78","description":"Mean change in apolipoprotein B (ApoB) from Week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"0.23","spread":"0.4"},{"groupId":"OG004","value":"0.17","spread":"0.4"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Highly Sensitive C-reactive Protein (hsCRP) at Week 26","description":"Calculated as an estimate of the mean change from baseline in highly sensitive C-reactive protein (hsCRP) at week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.02","spread":"0.31"},{"groupId":"OG001","value":"-0.99","spread":"0.31"},{"groupId":"OG002","value":"-0.66","spread":"0.31"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Plasminogen Activator Inhibitor-1 (PAI-1) at Week 26.","description":"Calculated as an estimate of the mean change from baseline in plasminogen activator inhibitor-1 (PAI-1) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-833","spread":"945.1"},{"groupId":"OG001","value":"-561","spread":"941.1"},{"groupId":"OG002","value":"586","spread":"952"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Interleukin-6 (IL-6) at Week 26.","description":"Calculated as an estimate of the mean change from baseline in interleukin-6 (IL-6) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.70","spread":"2.49"},{"groupId":"OG001","value":"1.71","spread":"2.47"},{"groupId":"OG002","value":"0.91","spread":"2.49"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in N-terminal Pro B-type Natriuretic Peptide (NT-proBNP) at Week 26.","description":"Calculated as an estimate of the mean change from baseline in N-terminal pro B-type Natriuretic Peptide (NT-proBNP) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.19","spread":"2.07"},{"groupId":"OG001","value":"3.74","spread":"2.06"},{"groupId":"OG002","value":"3.71","spread":"2.07"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Adiponectin at Week 26.","description":"Calculated as an estimate of the mean change from baseline in Adiponectin at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.69","spread":"0.19"},{"groupId":"OG001","value":"1.51","spread":"0.19"},{"groupId":"OG002","value":"1.35","spread":"0.19"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Tumour Necrosis Factor Alpha (TNF-alpha) at Week 26.","description":"Calculated as an estimate of the mean change from baseline in Tumour Necrosis Factor Alpha (TNF-alpha) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.55","spread":"0.25"},{"groupId":"OG001","value":"-0.74","spread":"0.25"},{"groupId":"OG002","value":"-0.53","spread":"0.25"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Von Willebrand Factor (vWf) at Week 26.","description":"Calculated as an estimate of the mean change from baseline in von Willebrand Factor (vWf) at Week 26. vWf is a blood glycoprotein involved in haemostasis.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.73","spread":"2.77"},{"groupId":"OG001","value":"-4.34","spread":"2.76"},{"groupId":"OG002","value":"-1.8","spread":"2.82"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Waist to Hip Ratio at Week 26.","description":"Calculated as an estimate of the mean change from baseline in Waist to Hip Ratio at Week 26. The measure is assessed as the circumference of the waist divided by the circumference of the hip.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.01","spread":"0.00"},{"groupId":"OG001","value":"-0.01","spread":"0.00"},{"groupId":"OG002","value":"-0.00","spread":"0.00"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Waist to Hip Ratio at Week 52","description":"Calculated as an estimate of the mean change from baseline in Waist to Hip Ratio at Week 52. The measure is assessed as the circumference of the waist divided by the circumference of the hip.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.00","spread":"0.00"},{"groupId":"OG001","value":"-0.01","spread":"0.00"},{"groupId":"OG002","value":"-0.00","spread":"0.00"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Waist to Hip Ratio From Week 52 to Week 78","description":"Mean change in Waist to Hip Ratio from Week 52 to Week 78. The measure is assessed as the circumference of the waist divided by the circumference of the hip.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"-0.01","spread":"0"},{"groupId":"OG004","value":"-0.00","spread":"0"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Waist Circumference at Week 26.","description":"Calculated as an estimate of the mean change from baseline in Waist Circumference at Week 26","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.69","spread":"0.35"},{"groupId":"OG001","value":"-2.63","spread":"0.36"},{"groupId":"OG002","value":"-1.12","spread":"0.36"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Waist Circumference at Week 52","description":"Calculated as an estimate of the mean change from baseline in Waist Circumference at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.36","spread":"0.38"},{"groupId":"OG001","value":"-3.02","spread":"0.38"},{"groupId":"OG002","value":"-1.23","spread":"0.38"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Waist Circumference From Week 52 to Week 78","description":"Mean change in Waist Circumference from Week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"-1.33","spread":"3.5"},{"groupId":"OG004","value":"-2.05","spread":"4.1"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Systolic Blood Pressure (SBP) at Week 26","description":"Calculated as an estimate of the mean change from baseline in Systolic Blood Pressure (SBP) at Week 26","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.55","spread":"0.89"},{"groupId":"OG001","value":"-0.72","spread":"0.89"},{"groupId":"OG002","value":"-0.94","spread":"0.89"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Systolic Blood Pressure (SBP) at Week 52","description":"Calculated as an estimate of the mean change from baseline in systolic blood pressure (SBP) at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.37","spread":"0.93"},{"groupId":"OG001","value":"-2.55","spread":"0.93"},{"groupId":"OG002","value":"-1.03","spread":"0.93"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Systolic Blood Pressure (SBP) From Week 52 to Week 78","description":"Mean change in systolic blood pressure (SBP) from Week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"-2.12","spread":"14.6"},{"groupId":"OG004","value":"0.35","spread":"12.4"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Diastolic Blood Pressure (DBP) at Week 26","description":"Calculated as an estimate of the mean change from baseline in diastolic blood pressure (DBP) at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.71","spread":"0.60"},{"groupId":"OG001","value":"0.07","spread":"0.59"},{"groupId":"OG002","value":"-1.78","spread":"0.60"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Diastolic Blood Pressure (DBP) at Week 52","description":"Calculated as an estimate of the mean change from baseline in diastolic blood pressure (DBP) at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.53","spread":"0.57"},{"groupId":"OG001","value":"-0.87","spread":"0.57"},{"groupId":"OG002","value":"-1.47","spread":"0.57"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Diastolic Blood Pressure (DBP) From Week 52 to Week 78","description":"Mean change in diastolic blood pressure (DBP) from Week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"-0.60","spread":"10.0"},{"groupId":"OG004","value":"0.03","spread":"8.9"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Pulse at Week 26","description":"Calculated as an estimate of the mean change from baseline in pulse at Week 26.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.32","spread":"0.59"},{"groupId":"OG001","value":"3.94","spread":"0.58"},{"groupId":"OG002","value":"-0.64","spread":"0.59"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Pulse at Week 52","description":"Calculated as an estimate of the mean change from baseline in pulse at Week 52.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.72","spread":"0.60"},{"groupId":"OG001","value":"3.09","spread":"0.60"},{"groupId":"OG002","value":"0.09","spread":"0.60"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Pulse From Week 52 to Week 78","description":"Mean change in pulse from Week 52 to Week 78.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"0.90","spread":"8.4"},{"groupId":"OG004","value":"2.19","spread":"7.7"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Overall Treatment Satisfaction (OTS) at Week 26","description":"The Overall Treatment Satisfaction is a sum of 6 items from the Diabetes Treatment Satisfaction Questionnaire, which is a self-assessment of treatment satisfaction. The scale of each sub-item goes from 0 (lowest satisfaction) to 6 (highest satisfaction) and the overall scale of OTS therefore goes from 0 to 36.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.51","spread":"0.49"},{"groupId":"OG001","value":"4.35","spread":"0.48"},{"groupId":"OG002","value":"2.96","spread":"0.48"}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Overall Treatment Satisfaction (OTS) at Week 52","description":"The Overall Treatment Satisfaction is a sum of 6 items from the Diabetes Treatment Satisfaction Questionnaire, which is a self-assessment of treatment satisfaction. The scale of each sub-item goes from 0 (lowest satisfaction) to 6 (highest satisfaction) and the overall scale of OTS therefore goes from 0 to 36.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.32","spread":"0.49"},{"groupId":"OG001","value":"4.31","spread":"0.48"},{"groupId":"OG002","value":"2.96","spread":"0.48"}]}]}]},{"type":"SECONDARY","title":"Mean Change in Overall Treatment Satisfaction (OTS) From Week 52 to Week 78","description":"The Overall Treatment Satisfaction is a sum of 6 items from the Diabetes Treatment Satisfaction Questionnaire, which is a self-assessment of treatment satisfaction. The scale of each sub-item goes from 0 (lowest satisfaction) to 6 (highest satisfaction) and the overall scale of OTS therefore goes from 0 to 36.","classes":[{"categories":[{"measurements":[{"groupId":"OG003","value":"1.48","spread":"4.4"},{"groupId":"OG004","value":"0.98","spread":"6.1"}]}]}]},{"type":"SECONDARY","title":"Hypoglyceamic Episodes, Weeks 0-26","description":"Number of hypoglycaemic episodes from Week 0 to Week 26, defined as major, minor, or symptoms only. Major if unable to treat her/himself. Minor if able to treat her/himself and plasma glucose below 3.1 mmol/L. Symptoms only if able to treat her/himself and no plasma glucose measurement or plasma glucose higher than or equal to 3.1 mmol/L.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"37","spread":null},{"groupId":"OG002","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"15","spread":null},{"groupId":"OG002","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Hypoglycaemic Episodes (Excluding Outlier Subject), Weeks 0-26","description":"Number of hypoglycaemic episodes from Week 0 to Week 26, defined as major, minor, or symptoms only. Major if unable to treat her/himself. Minor if able to treat her/himself and plasma glucose below 3.1 mmol/L. Symptoms only if able to treat her/himself and no plasma glucose measurement or plasma glucose higher than or equal to 3.1 mmol/L.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"16","spread":null},{"groupId":"OG002","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"15","spread":null},{"groupId":"OG002","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Hypoglyceamic Episodes, Weeks 0-52","description":"Number of hypoglycaemic episodes from Week 0 to Week 52, defined as major, minor, or symptoms only. Major if unable to treat her/himself. Minor if able to treat her/himself and plasma glucose below 3.1 mmol/L. Symptoms only if able to treat her/himself and no plasma glucose measurement or plasma glucose higher than or equal to 3.1 mmol/L.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"51","spread":null},{"groupId":"OG002","value":"25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"29","spread":null},{"groupId":"OG002","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Hypoglycaemic Episodes (Excluding Outlier Subject), Weeks 0-52","description":"Number of hypoglycaemic episodes from Week 0 to Week 52, defined as major, minor, or symptoms only. Major if unable to treat her/himself. Minor if able to treat her/himself and plasma glucose below 3.1 mmol/L. Symptoms only if able to treat her/himself and no plasma glucose measurement or plasma glucose higher than or equal to 3.1 mmol/L.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"28","spread":null},{"groupId":"OG002","value":"25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"29","spread":null},{"groupId":"OG002","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Hypoglyceamic Episodes, Weeks 0-78","description":"Number of hypoglycaemic episodes from Week 0 to Week 78, defined as major, minor, or symptoms only. Major if unable to treat her/himself. Minor if able to treat her/himself and plasma glucose below 3.1 mmol/L. Symptoms only if able to treat her/himself and no plasma glucose measurement or plasma glucose higher than or equal to 3.1 mmol/L.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36","spread":null},{"groupId":"OG001","value":"56","spread":null},{"groupId":"OG002","value":"34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"40","spread":null},{"groupId":"OG002","value":"13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Hypoglycaemic Episodes (Excluding Outlier Subject), Weeks 0-78","description":"Number of hypoglycaemic episodes from Week 0 to Week 78, defined as major, minor, or symptoms only. Major if unable to treat her/himself. Minor if able to treat her/himself and plasma glucose below 3.1 mmol/L. Symptoms only if able to treat her/himself and no plasma glucose measurement or plasma glucose higher than or equal to 3.1 mmol/L.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36","spread":null},{"groupId":"OG001","value":"33","spread":null},{"groupId":"OG002","value":"34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"40","spread":null},{"groupId":"OG002","value":"13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Hypoglycaamic Episodes, Weeks 52-78","description":"Number of hypoglycaemic episodes from Week 52 to Week 78, defined as major, minor, or symptoms only. Major if unable to treat her/himself. Minor if able to treat her/himself and plasma glucose below 3.1 mmol/L. Symptoms only if able to treat her/himself and no plasma glucose measurement or plasma glucose higher than or equal to 3.1 mmol/L.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG003","value":"3","spread":null},{"groupId":"OG004","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":12,"n":221},"commonTop":["Nausea","Nasopharyngitis","Headache","Diarrhoea","Vomiting"]}}}